Example logo GIS 26

Global Innovation Summit 2026

6 May 2026 | Basel, Switzerland

Home
Register
Register
Register

PartnershipUpdated on 28 April 2026

Pharma / Biotech partner to collaborate on Non Animal Testing models

Debraj Dasgupta

Managing Director, Inventicia GmbH at Inventicia GmbH

Basel, Switzerland

About

Revolutionizing the strategy of testing drugs and vaccines.

Digital Animal Replacement Technology (#DART) is a cutting-edge innovation that aligns with the FDA’s Roadmap in phasing out animal models and the 3Rs mandate (Reduce, Refine, Replace). By integrating human biology-driven systems with advanced AI and machine learning, DART transforms safety and efficacy evaluations in drug and vaccine development.

Using human MicroPhysiological Systems (#hMPS) from ethically immuned sources, DART mimics tissue microenvironments to generate clinically translatable insights. Its AI analytics manage complex biological datasets, enabling the identification of phenomics perturbations, dose-response generation, benchmarking, and comprehensive reporting. This approach enhances the reliability and scalability of evaluations.

💡 Learn how human-relevant platforms are bridging the translational gap from discovery to clinical success.

Join us at our special event in Basel on 7th May (8:30 - 10 am CET), where our founder, Dr. S Dravida (She/Her), will showcase DART and how human-relevant platforms are bridging the translational gap from discovery to clinical success.

🔗Please register using the link below:

https://lnkd.in/g5xQGaRz

#DART #invitro #hMPS #AI #ML #BioFMs #vaccines #biologics #exvivio #3Rs #NAMs #FDA #TranscellBiologics #CGT #NBEs #Discovery #Preclinical #Innovation #3D #Animalfree #Nonanimal #Drugdiscovery #cl

Attached files

Organisation

Inventicia GmbH

SME

Basel, Switzerland

Similar opportunities